Trial Profile
Ixazomib, Lenalidomide, and Dexamethasone for Patients With POEMS Syndrome
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2023
Price :
$35
*
At a glance
- Drugs Dexamethasone (Primary) ; Ixazomib (Primary) ; Lenalidomide (Primary)
- Indications POEMS syndrome
- Focus Therapeutic Use
- 03 Nov 2023 Planned End Date changed from 15 Dec 2023 to 31 Oct 2024.
- 20 Oct 2023 Planned End Date changed from 15 Oct 2023 to 15 Dec 2023.
- 09 Nov 2022 Planned End Date changed from 15 Oct 2022 to 15 Oct 2023.